Computational drug discovery leveraging generative AI to create therapeutics for neurodegenerative disorders.
Description
NeuroX1 is a computational drug design startup building a platform to identify drivers of neurodegenerative/neurological diseases then using Chiron, a propritary generative chemistry platform, designs novel compounds for those diseases.